Who owns Cidara Therapeutics Inc Common Stock Usd 0.0001?
- Ticker: CDTX
- CUSIP Number: 171757107
Tip: Access positions for across all investors
Analyze quarterly positions in Cidara Therapeutics Inc Common Stock Usd 0.0001 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cidara Therapeutics Inc Common Stock Usd 0.0001 stock
Who bought or sold Cidara Therapeutics Inc Common Stock Usd 0.0001 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 6.9M | $6.3M | 0% | Mar 2024 |
|
| Vanguard Group | 3.3M | $3.1M | 0% | Mar 2024 |
|
| Alethea Capital Management | 1.6M | $1.5M | -2% | Mar 2024 |
|
| Point72 Asset Management | 1.3M | $1.2M | 0% | Mar 2024 |
|
| 5AM Venture Management | 1.1M | $1.0M | 0% | Mar 2024 |
|
| Geode Capital Management | 838k | $771k | 4% | Mar 2024 |
|
| BlackRock | 715k | $658k | -24% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 552k | $508k | -13% | Mar 2024 |
|
| GSA Capital Partners | 457k | $420k | -16% | Mar 2024 |
|
| Monashee Investment Management | 369k | $340k | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 317k | $292k | 0% | Mar 2024 |
|
| Us Bancorp | 262k | $241k | 0% | Mar 2024 |
|
| Tocqueville Asset Management | 163k | $150k | 72% | Mar 2024 |
|
| Northern Trust | 160k | $147k | 25% | Mar 2024 |
|
| Jeppson Wealth Management | 149k | $137k | 4% | Mar 2024 |
|
| Callan Capital | 95k | $88k | -8% | Mar 2024 |
|
| Citadel Advisors | 87k | $80k | 100% | Mar 2024 |
|
| XTX Topco | 79k | $73k | -61% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 78k | $71k | -2% | Mar 2024 |
|
| Two Sigma Investments | 67k | $62k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 60k | $55k | 0% | Mar 2024 |
|
| FNY Investment Advisers | 57k | $52k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 53k | $48k | 0% | Mar 2024 |
|
| Jane Street | 46k | $42k | 233% | Mar 2024 |
|
| Mackenzie Financial | 39k | $36k | 56% | Mar 2024 |
|
| Legacy Wealth Asset Management | 30k | $28k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 27k | $25k | 0% | Mar 2024 |
|
| Two Sigma Advisers | 24k | $22k | -41% | Mar 2024 |
|
| Russell Investments | 17k | $16k | 0% | Mar 2024 |
|
| Morgan Stanley | 16k | $14k | -92% | Mar 2024 |
|
| Liberty Wealth Management | 12k | $11k | 0% | Mar 2024 |
|
| Pure Financial Advisors | 12k | $11k | 0% | Mar 2024 |
|
| Spire Wealth Management | 10k | $9.2k | 101% | Mar 2024 |
|
| Mariner Wealth Advisors | 10k | $9.2k | 100% | Mar 2024 |
|
| Tower Research Capital | 9.0k | $8.3k | 226% | Mar 2024 |
|
| Pacifica Partners | 8.0k | $5.9k | 0% | Mar 2024 |
|
| UBS Group | 4.7k | $4.3k | 100% | Mar 2024 |
|
| Wetzel Investment Advisors | 4.0k | $2.9k | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 800.00 | $736.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 643.00 | $592.010100 | 2% | Mar 2024 |
|
| Simplex Trading | 525.00 | $0 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 451.00 | $414.018000 | -69% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 353.00 | $325.007100 | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 290.00 | $267.003000 | 27% | Mar 2024 |
|
| Qube Research & Technologies | 52.00 | $48.001200 | -98% | Mar 2024 |
|
Who sold out of Cidara Therapeutics Inc Common Stock Usd 0.0001?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Dec 2023 | 1.5M | $1.2M |
| Bank of New York Mellon | Dec 2023 | 127k | $101k |
| Virtu Financial | Dec 2023 | 96k | $76k |
| Two Sigma Securities | Dec 2023 | 37k | $29k |
| Aveo Capital Partners | Dec 2023 | 23k | $18k |
| Susquehanna International | Sep 2023 | 20k | $19k |
| Royal Bank of Canada | Dec 2023 | 246.00 | $0 |
| Bank of America Corporation | Dec 2023 | 53.00 | $42.002500 |